Intravenous Infusions (XGHA:IIL) ROE % Adjusted to Book Value : 0.00% (As of . 20)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions ROE % Adjusted to Book Value?

Intravenous Infusions's ROE % for the quarter that ended in . 20 was 0.00%. Intravenous Infusions's PB Ratio for the quarter that ended in . 20 was N/A. Intravenous Infusions's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

Intravenous Infusions ROE % Adjusted to Book Value Historical Data

The historical data trend for Intravenous Infusions's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions ROE % Adjusted to Book Value Chart

Intravenous Infusions Annual Data

Trend

ROE % Adjusted to Book Value

Intravenous Infusions Semi-Annual Data

ROE % Adjusted to Book Value

Competitive Comparison of Intravenous Infusions's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's ROE % Adjusted to Book Value falls into.

Intravenous Infusions ROE % Adjusted to Book Value Calculation

Intravenous Infusions's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Intravenous Infusions's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Intravenous Infusions ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions (XGHA:IIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.